<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38449921</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6-12 Months Postinfection.</ArticleTitle><Pagination><StartPage>ofae027</StartPage><MedlinePgn>ofae027</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae027</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae027</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Few longitudinal studies available characterize long COVID outcomes out to 24 months, especially in people with nonsevere acute coronavirus disease 2019 (COVID-19). This study sought to prospectively characterize incidence and duration of long COVID symptoms and their association with quality of life (QoL) from 1-24 months after mild-to-moderate COVID-19 using validated tools in a diverse cohort of unvaccinated people infected with SARS-CoV-2 in 2020.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">At 1-3, 6, 12, 18, and 24 months post-COVID-19, 70 participants had orthostatic vital signs measured, provided blood, and completed surveys characterizing symptoms, QoL, and return to pre-COVID-19 health and activities using validated tools (FLU-PRO+, Fatigue Severity Scale, Insomnia Severity Index, General Practitioner Assessment of Cognition, Patient Health Questionnaire Depression 8-Item, Generalized Anxiety Disorder 7-Item, 36-Item Short-Form Health Survey, EuroQol EQ-5D-5L).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During the study period, 33% of participants experienced long COVID (had not returned to pre-COVID-19 health status and reported at least 1 symptom &gt;90 days postinfection); 8% had not returned to their pre-COVID-19 health status 24 months postinfection. Long COVID symptoms peaked 6 months post-COVID-19, frequently causing activity limitations. Having long COVID was significantly associated with decreased QoL in multiple domains. Frequencies of orthostatic hypotension and tachycardia reflected levels reported in the general population. Within-person weight increased significantly between months 1 and 6. Long COVID was associated with pre-COVID-19 obesity and hyperlipidemia, but not with high-sensitivity C-reactive protein levels 1-3 months postinfection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Long COVID occurs in a significant proportion of unvaccinated people, even if the acute illness was not severe. Long COVID prevalence peaked 6-12 months post-COVID-19, and a small proportion of participants still reported not returning to their pre-COVID-19 health status 24 months post-COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demko</LastName><ForeName>Zoe O</ForeName><Initials>ZO</Initials><Identifier Source="ORCID">0000-0003-2122-820X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullapudi</LastName><ForeName>Sarika K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela Heslin</LastName><ForeName>M Gabriela</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorsey</LastName><ForeName>Chamia A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payton</LastName><ForeName>Christine B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tornheim</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Austere Environments Consortium for Enhanced Sepsis Outcomes, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Shruti H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>David L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manabe</LastName><ForeName>Yukari C</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antar</LastName><ForeName>Annukka A R</ForeName><Initials>AAR</Initials><Identifier Source="ORCID">0000-0002-6775-1103</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AI135102</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 EB007958</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2022 Aug 09:2022.08.08.22278543. doi: 10.1101/2022.08.08.22278543</RefSource><PMID Version="1">35982674</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">longitudinal cohort</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. Y. C. M. has received research grant support to Johns Hopkins University from Hologic, Cepheid, Roche, ChemBio, Becton Dickinson, and miDiagnostics, and has provided consultative support to Abbott, outside the present work. All other authors report no potential conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38449921</ArticleId><ArticleId IdType="pmc">PMC10917418</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae027</ArticleId><ArticleId IdType="pii">ofae027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen &#xa0;C, Haupert &#xa0;SR, Zimmermann &#xa0;L, Shi &#xa0;X, Fritsche &#xa0;LG, Mukherjee &#xa0;B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis &#xa0;2022; 226:1593&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard &#xa0;F, Perego &#xa0;E. How and why patients made long Covid. Soc Sci Med &#xa0;2021; 268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, McCorkell &#xa0;L, Vogel &#xa0;JM, Topol &#xa0;EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol &#xa0;2023; 21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati &#xa0;M, Udeh &#xa0;R, Yon &#xa0;DK, et al. &#xa0;A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol &#xa0;2023; 95:e28852.</Citation><ArticleIdList><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, Assaf &#xa0;GS, McCorkell &#xa0;L, et al. &#xa0;Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine &#xa0;2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai &#xa0;T, Jolley &#xa0;SE, Karlson &#xa0;EW, et al. &#xa0;Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA &#xa0;2023; 329:1934&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics . Long COVID: Household Pulse Survey. Atlanta, GA: Centers for Disease Control and Prevention; 2023.</Citation></Reference><Reference><Citation>Ballouz &#xa0;T, Menges &#xa0;D, Anagnostopoulos &#xa0;A, et al. &#xa0;Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ &#xa0;2023; 381:e074425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering &#xa0;AV, van Zon &#xa0;SKR, Olde Hartman &#xa0;TC, Rosmalen &#xa0;JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet &#xa0;2022; 400:452&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnachie &#xa0;E, Hapfelmeier &#xa0;A, Linde &#xa0;K, et al. &#xa0;Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: a retrospective cohort study using routinely collected claims data. BMJ Open &#xa0;2022; 12:e064979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9511014</ArticleId><ArticleId IdType="pubmed">36137635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as &#xa0;C, Mart&#xed;n-Guerrero &#xa0;JD, Cancela-Cilleruelo &#xa0;I, Moro-L&#xf3;pez-Menchero &#xa0;P, Rodr&#xed;guez-Jim&#xe9;nez &#xa0;J, Pellicer-Valero &#xa0;OJ. Exploring the trajectory recovery curve of the number of post-COVID symptoms: the LONG-COVID-EXP-CM Multicenter Study. Int J Infect Dis &#xa0;2022; 117:201&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826603</ArticleId><ArticleId IdType="pubmed">35150911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Martinez &#xa0;L, Karten &#xa0;J, Kritzer &#xa0;MD, et al. &#xa0;Post-acute sequelae of SARS-CoV-2 infection: a descriptive clinical study. J Neuropsychiatry Clin Neurosci &#xa0;2022; 34:393&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">35686346</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;L, Li &#xa0;X, Gu &#xa0;X, et al. &#xa0;Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med &#xa0;2022; 10:863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;D, Liao &#xa0;X, Liu &#xa0;Z, et al. &#xa0;Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study. Emerg Microbes Infect &#xa0;2022; 11:1&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639507</ArticleId><ArticleId IdType="pubmed">36215047</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Sillett &#xa0;R, Zhu &#xa0;L, et al. &#xa0;Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry &#xa0;2022; 9:815&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Musheyev &#xa0;B, Boparai &#xa0;MS, Kimura &#xa0;R, et al. &#xa0;Longitudinal medical subspecialty follow-up of critically and non-critically ill hospitalized COVID-19 survivors up to 24 months after discharge. Intern Emerg Med &#xa0;2023; 18:477&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887251</ArticleId><ArticleId IdType="pubmed">36719540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang &#xa0;H, Li &#xa0;X, Huang &#xa0;L, et al. &#xa0;Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study. EClinicalMedicine &#xa0;2022; 54:101668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514976</ArticleId><ArticleId IdType="pubmed">36188433</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong &#xa0;SW, Goh &#xa0;YS, Torres-Ruesta &#xa0;A, et al. &#xa0;Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection. J Med Virol &#xa0;2023; 95:e28774.</Citation><ArticleIdList><ArticleId IdType="pubmed">37212320</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair &#xa0;PW, Brown &#xa0;DM, Jang &#xa0;M, et al. &#xa0;The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis &#xa0;2021; 8:ofab007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881750</ArticleId><ArticleId IdType="pubmed">33614816</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard &#xa0;SA, Epsi &#xa0;NJ, Pollett &#xa0;S, et al. &#xa0;Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) instrument in patients with coronavirus disease 2019. Open Forum Infect Dis &#xa0;2021; 8:ofab517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661080</ArticleId><ArticleId IdType="pubmed">34901299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim &#xa0;MJ, FFarrell &#xa0;J. Orthostatic hypotension: a practical approach. Am Fam Physician &#xa0;2022; 105:39&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">35029940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastian &#xa0;SA, Co &#xa0;EL, Panthangi &#xa0;V, et al. &#xa0;Postural orthostatic tachycardia syndrome (POTS): an update for clinical practice. Curr Probl Cardiol &#xa0;2022; 47:101384.</Citation><ArticleIdList><ArticleId IdType="pubmed">36055438</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris &#xa0;PA, Taylor &#xa0;R, Thielke &#xa0;R, Payne &#xa0;J, Gonzalez &#xa0;N, Conde &#xa0;JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform &#xa0;2009; 42:377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . Stata statistical software: release 16. College Station, TX: StataCorp, LLC; 2019.</Citation></Reference><Reference><Citation>Cihakova &#xa0;D, Streiff &#xa0;MB, Menez &#xa0;SP, et al. &#xa0;High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol &#xa0;2021; 16:691&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457535</ArticleId><ArticleId IdType="pubmed">34567235</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrepo &#xa0;BJ. Obesity prevalence among U.S. adults during the COVID-19 pandemic. Am J Prev Med &#xa0;2022; 63:102&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977388</ArticleId><ArticleId IdType="pubmed">35725124</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as &#xa0;C, Rodr&#xed;guez-Jim&#xe9;nez &#xa0;J, Cancela-Cilleruelo &#xa0;I, et al. &#xa0;Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients. JAMA Netw Open &#xa0;2022; 5:e2242106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9667330</ArticleId><ArticleId IdType="pubmed">36378309</ArticleId></ArticleIdList></Reference><Reference><Citation>Debski &#xa0;M, Tsampasian &#xa0;V, Haney &#xa0;S, et al. &#xa0;Post-COVID-19 syndrome risk factors and further use of health services in East England. PLoS Glob Public Health &#xa0;2022; 2:e0001188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022108</ArticleId><ArticleId IdType="pubmed">36962824</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson &#xa0;EJ, Williams &#xa0;DM, Walker &#xa0;AJ, et al. &#xa0;Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun &#xa0;2022; 13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati &#xa0;L, De Maria &#xa0;L, Quarato &#xa0;M, et al. &#xa0;Association between long COVID and overweight/obesity. J Clin Med &#xa0;2021; 10:4143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapa &#xa0;J, Rosa &#xa0;D, Mendes &#xa0;JPL, Deusdar&#xe1; &#xa0;R, Romero &#xa0;GAS. Prevalence and associated factors of post-COVID-19 syndrome in a Brazilian cohort after 3 and 6 months of hospital discharge. Int J Environ Res Public Health &#xa0;2023; 20:848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9820092</ArticleId><ArticleId IdType="pubmed">36613170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller &#xa0;MC, Liang &#xa0;CJ, Marques &#xa0;AR, et al. &#xa0;A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med &#xa0;2022; 175:969&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Kelly &#xa0;JD, Lu &#xa0;S, et al. &#xa0;Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis &#xa0;2022; 9:ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko &#xa0;PO, Bassetti &#xa0;CL, Bloch &#xa0;KE, Held &#xa0;U, Baumann &#xa0;CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep &#xa0;2008; 31:1601&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali &#xa0;ST, Kang &#xa0;AK, Patel &#xa0;TR, et al. &#xa0;Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers.&#x201d; &#xa0;Ann Clin Transl Neurol &#xa0;2022; 9:950&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>McFann &#xa0;K, Baxter &#xa0;BA, LaVergne &#xa0;SM, et al. &#xa0;Quality of life (QoL) is reduced in those with severe COVID-19 disease, post-acute sequelae of COVID-19, and hospitalization in United States adults from northern Colorado. Int J Environ Res Public Health &#xa0;2021; 18:11048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582735</ArticleId><ArticleId IdType="pubmed">34769566</ArticleId></ArticleIdList></Reference><Reference><Citation>Noujaim &#xa0;PJ, Jolly &#xa0;D, Coutureau &#xa0;C, Kanagaratnam &#xa0;L. Fatigue and quality-of-life in the year following SARS-Cov2 infection. BMC Infect Dis &#xa0;2022; 22:541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189445</ArticleId><ArticleId IdType="pubmed">35698068</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien &#xa0;K, Townsend &#xa0;L, Dowds &#xa0;J, et al. &#xa0;1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir Res &#xa0;2022; 23:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067558</ArticleId><ArticleId IdType="pubmed">35509060</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof &#xa0;L, Tosto-Mancuso &#xa0;J, Wood &#xa0;J, et al. &#xa0;Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil &#xa0;2022; 101:48&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick &#xa0;JL, Titus &#xa0;AR, Slocum &#xa0;E, et al. &#xa0;Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis &#xa0;2021; 73:2055&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>